Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Dulaglutide

Weekly GLP-1 Receptor Agonists in Obese Individuals Without Diabetes

Company n/r · Phase 3 · Completed · Enrollment 150

NCT07834398

ArmPopulationDoseWeeksEstimandWeight change
Dulaglutide GroupObesity or overweightn/r24n/rn/r
Semaglutide GroupObesity or overweightn/r24n/rn/r
Tirzepatide GroupObesity or overweightn/r24n/rn/r